Introducing New Amino Acids into Proteins.

Abstract

INTRODUCTION. The introduction of new amino acids into proteins presents a special challenge because, throughout the three kingdoms of life, the same 20 amino acids are used as the building blocks for all proteins. These building blocks have emerged from a long history of evolution when other amino acids were undoubtedly incorporated into early proteins. The use of the same amino acids in contemporary proteins is a direct result of the universal genetic code. The code, in turn, is established in the aminoacylation reactions catalyzed by aminoacyl transfer RNA (tRNA) synthetases. In these reactions, a specific amino acid is joined to the tRNA that bears the anticodon triplet corresponding to that amino acid. The tRNA synthetases themselves are ancient proteins whose evolution is thought to be closely tied to the development of the universal genetic code. The introduction of new amino acids into proteins has at least two motivations. One is the practical value of producing proteins with novel activities or chemical properties that go beyond what is known for natural proteins. For example, proteins with novel catalytic groups, spectroscopic characteristics, or special surface properties could have a variety of applications. The other motivation is centered on the question of the origin of life and the transition from the putative RNA world to the theatre of proteins. This transition centers on the development of the genetic code and the appearance of proteins that may have contained amino acids other than or in addition to ones found in contemporary proteins. The early code probably was ambiguous, that is, a primitive codon could code for more than one amino acid. With these considerations in mind, efforts were directed at “invading” the genetic code so as to make possible the introduction of new amino acids into proteins. Because of their central role in establishing the code, a member of the aminoacyl tRNA synthetase set of enzymes was manipulated for these purposes. RESULTS. Valyl-tRNA synthetase (ValRS) catalyzes the aminoacylation of tRNA Val in a twostep reaction. First, the enzyme condenses valine with ATP to yield a tightly bound valyladenylate. Next, the valyl adenylate is reacted with the 3’-end of tRNA Val to yield Val-tRNA Val . In this way, valine is assigned to a specific nucleotide triplet (the tRNA anticodon) in the algorithm of the genetic code. ValRS has two catalytic sites. One site is part of the catalytic center for the aminoacylation reaction. A pocket in the enzyme holds the isopropyl side chain of valine. However, the side chain of threonine, which replaces a single methyl group of valine with a hydroxyl group, can fit into the same pocket. As a consequence, ValRS will occasionally misactivate threonine and catalyze